Filter posts

The Convergence of BioPharma and Digital Medicine

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing …

Out of Africa: Biomedical Innovation and Expertise

Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden …

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

Leading MIT Scientist, Professor and Entrepreneur, Robert Langer, to Speak at BIO 2015

In a recent Boston Globe article, MIT standout and Queen Elizabeth Prize for Engineering recipient, …

United Health To Congress: Let Cancer Patients Eat Gauze (Op-Ed in The Hill)

Jonathan Wilcox’s op-ed in The Hill today highlights the growing challenge of insurance company tactics that …

Dr. Eric Topol to Keynote Wednesday Luncheon at #BIO2015

This week, we are very excited to announce that Dr. Eric J. Topol, director of …

Coalition Offers a Remedy for Stagnated Clinical Trials

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A …

Webinar Today: Comparative Effectiveness Research

As we continue to see new strides in biopharmaceutical innovation, there is increasing value in …

New PhRMA Report: A Decade of Innovation in Rare Diseases

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released “A Decade of Innovation in …

Biotech Could Miss a Multi-Billion Dollar Opportunity in Rare Disease

Drug development is expensive.  Drug development is risky.  Drug development takes a long time. The …